EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Revolutionizing Healthcare: Gene Editing for Genetic Disorders with CRISPR Technology
Gene editing using CRISPR Clustered Regularly Interspaced Short Palindromic Repeats technology has the potential to revolutionize healthcare particularly in addressing genetic disorders
Manufacturing mRNA, Cell, and Gene Therapies at Commercial Scale
Why Cell and Gene Therapies Fail in Europe After the Science Has Already Worked The uncomfortable statistic for anyone financing advanced therapies in Europe is not the clinical attrition rate It is the withdrawal rate after approval An analysis of advanced therapy medicinal products granted European marketing authorisation found that roughly one in five had subsequently been withdrawn and of th...
Plant-derived Edible Nanoparticles in Delivering Cancer Drugs: Fact or Fad?
Plantderived edible nanoparticles PDENPs are nanosizedvesicles obtained from edible plants such as grapefruit curcumin ginger broccoli and lemon They contain miRNAs bioactive lipids and proteins which play an important role in cell signaling regulation of plant immunity and transport of bioactive molecules into mammalian cells As the world attempts to overcome
How Can Smart Packaging Revolutionize Pharma with Track-and-Trace Solutions?
Did you know that smart packaging has the potential to revolutionize the pharmaceutical industry With trackandtrace solutions this innovative technology can enhance transparency safety and efficiency in the pharma supply chain
Pain Points and Progress: Navigating the Complexities of Life Sciences Logistics
Within recent years there has been a new facet of complexity in the supply chain pathways of the life sciences industry From rising geopolitical tensions to trade wars logistics teams now have to operate in an environment shaped by rapid change regulatory scrutiny and unpredictable policy changes influenced by politics
Trapicolast Emerges as a First-In-Class Response to Drug Resistance: The Weakest
Malaria remains one of the worlds most persistent infectious diseases Each year it infects hundreds of millions and causes more than half a million deaths with subSaharan Africa bearing the overwhelming burden Children under five account for most fatalities highlighting malarias deep inequity
-
Techno Trends
University of Dundee’s Cabamiquine Shows Promise for Single-Dose Malaria Treatment
Researchers at the University of Dundee have reported encouraging clinical results for cabamiquine a novel antimalarial compound being developed as a potential singledose treatment for malaria
-
Projects
Genentech to Invest US$750 Million in Oregon Device Fill-Finish Facility
Genentech a member of the Roche Group plans to invest approximately US million in a new device fillfinish manufacturing facility at its acre campus in Hillsboro Oregon The project will add endtoend manufacturing
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Manufacturing mRNA, Cell, and Gene Therapies at Commercial Scale
Lakshmi
Commercial scale means something different for mRNA, autologous cell therapy and in vivo gene therapy, and Europe adds a fourth dimension the science cannot solve: scaling across twenty-seven jurisdic...
-
2
Plant-derived Edible Nanoparticles in Delivering Cancer Drugs: Fact or Fad?
Ryan Varghese
Abha Deshpande
Jainam Karsiya
Dileep Kumar
Globally, cancer has been referred to as one of the most debilitating diseases. The current treatment regimenfor the treatment of the same is limited to surgical, radiation, and chemotherapeutic inter...
-
3
How Can Smart Packaging Revolutionize Pharma with Track-and-Trace Solutions?
Kate Williamson
Smart packaging with track-and-trace solutions is revolutionizing the pharmaceutical industry by enhancing supply chain transparency, preventing counterfeit drugs, and improving patient safety. Techno...
-
4
Pain Points and Progress: Navigating the Complexities of Life Sciences Logistics
Vincent Howard
Rising geopolitical tensions and trade wars are adding to the complexity in the life sciences supply chain. This article looks at how logistics teams are tackling these challenges, from geopolitical i...
-
5
Trapicolast Emerges as a First-In-Class Response to Drug Resistance: The Weakest
Dr Vikram Venkateswaran
As malaria control stalls under rising drug resistance, Trapicolast, an AI-designed, first-in-class antimalarial, signals a strategic shift. By targeting dual essential parasite pathways and engineeri...
press releases Read more...
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
Revolution Medicines Inc Nasdaq RVMD a global commercialstage oncology company dedicated to discovering developing and delivering innovative medicines for patients with RASaddicted cancers today announced that the US Food and Drug Administration FDA has granted Breakthrough
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
Tenaya Therapeutics Inc NASDAQ TNYA a clinicalstage biotechnology company with a mission to discover develop and deliver potentially curative therapies that address the underlying causes of heart disease
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
Agomab Therapeutics NV Agomab a clinicalstage biopharmaceutical company focused on fibroinflammation today announced positive results of the Phase study of AGMB in IPF patients
BioLife receives US patent for novel effervescent tablet technology for oral peptide delivery
BioLife announced today that the US Patent and Trademark Office has granted US Patent B for its novel oral peptide delivery technology via effervescent tablets It was developed for current and future peptide therapies for obesity diabetes and metabolic disorders
Events Read more...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
LATEST NEWS Read more...
Asimov Partners with Sidewinder Therapeutics on Cell Line Development for Bispecific Antibody
Asimov has entered into a cell line development partnership with Sidewinder Therapeutics to support the development of a fourchain bispecific antibody candidate for solid tumour treatment
Sanofi and Cheplapharm Plan Strategic Partnership for Mature Medicines
Sanofi and Cheplapharm have announced plans to form a strategic partnership covering a selection of Sanofis mature medicines Under the proposed agreement Cheplapharm would acquire established
Renova Pharmaceuticals Launches First Three US Generic Products
Renova Pharmaceuticals has launched its first three generic products in the US marking a major milestone as the company moves from developing its product and regulatory pipeline to establishing a commercial presence in the US generics market
Community Clinical Research Joins PhaseWell Research to Expand CNS Clinical Trial Access in Te
PhaseWell Research has partnered with Community Clinical Research CCR in Austin Texas to strengthen its inpatient central nervous system CNS research capabilities and expand access to clinical trials across Texas
Sysmex Europe and Cytek Biosciences collaborate to expand access to advanced clinical flow cytometry
Sysmex Europe SE and Cytek Biosciences Inc have announced a strategic collaboration across more than a dozen European countries to improve clinical flow cytometry workflows and expand access to advanced diagnostic solutions
Ratio Therapeutics and RayzeBio enter collaboration to advance novel radiopharmaceutical programme
Ratio Therapeutics Inc has entered into a research collaboration and licence agreement with RayzeBio Inc to advance a new radiopharmaceutical programme focused on two undisclosed targets






